Guosheng Yang
Shanghai, 200092, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Normal kidney tissue derived extracellular vesicles suppress clear cell renal cell carcinoma progression via transfer their inhibitory miRNAs.
Journal: Cancer treatment and research communications
Published: February 26, 2026
Elimination of docetaxel-induced senescence attenuates malignant progression in RB1-deficient CRPC.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: May 04, 2025
Correction: BEX4 inhibits the progression of clear cell renal cell carcinoma by stabilizing SH2D4A, which is achieved by blocking SIRT2 activity.
Journal: Oncogene
Published: January 22, 2025
BEX4 inhibits the progression of clear cell renal cell carcinoma by stabilizing SH2D4A, which is achieved by blocking SIRT2 activity.
Journal: Oncogene
Published: April 26, 2024
Integrated analysis of histone modification features in clear cell renal cancer for risk stratification and therapeutic prediction.
Journal: Translational oncology
Published: December 14, 2023
Clinicopathological and immunological profiles of prostate adenocarcinoma and neuroendocrine prostate cancer.
Journal: World journal of surgical oncology
Published: July 22, 2022
A genomic mutation spectrum of collecting duct carcinoma in the Chinese population.
Journal: BMC medical genomics
Published: August 26, 2021
No significant association between immunosuppression in solid organ transplantation and prostate cancer risk: a meta-analysis of cohort studies.
Journal: Translational cancer research
Published: September 25, 2018
Influence of photoselective vaporization of the prostate on the sexual function of the patient
Journal: Zhonghua nan ke xue = National journal of andrology
Published: May 09, 2018
One-puncture one-needle TRUS-guided prostate biopsy for prevention of postoperative infections
Journal: Zhonghua nan ke xue = National journal of andrology
Published: May 04, 2018
Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells.
Journal: BMC cancer
Published: March 19, 2018
Last Updated: 09/26/2026